SpotitEarly: Funding, Investors & Team (Sep 2026)
SpotitEarly provides a pre-screening test for multiple types of cancer using just one breath sample. This convenient and innovative method enables individuals to perform cancer screenings from the comfort of their own home. The test is able to accurately detect Breast, Lung, Colon, and Prostate cancers. By streamlining the detection process, SpotitEarly hopes to improve early diagnosis, which is vital for successful treatment. The company is dedicated to making cancer detection easier and less invasive, meeting the needs of both patients and healthcare professionals. Through its distinct approach, SpotitEarly plays a key role in advancing health management and early intervention tactics.
SpotitEarly has raised $20.4M across 3 funding rounds on record, the most recent an undisclosed round of $100k announced in Dec 2025.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SpotitEarly Company Profile and Key Stats
Latest funding round on record: Dec 2025.
SpotitEarly Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
SpotitEarly announced an undisclosed round in Jan 2025; the amount was not disclosed.
4 months later, an undisclosed round of $20.3M was announced in May 2025.
7 months later, an undisclosed round of $100k was announced in Dec 2025.
SpotitEarly Founders and Leadership Team
Contact details for the SpotitEarly team: 3 of 3 have an email address on file.
Start 14-day free trial →SpotitEarly Funding Compared to Other Biotechnology Startups
SpotitEarly's latest round of $100k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SpotitEarly in Biotechnology and Englewood
Companies Similar to SpotitEarly
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
SpotitEarly Funding FAQs
What does SpotitEarly do?
SpotitEarly provides a pre-screening test for multiple types of cancer using just one breath sample. This convenient and innovative method enables individuals to perform cancer screenings from the comfort of their own home. The test is able to accurately detect Breast, Lung, Colon, and Prostate cancers. By streamlining the detection process, SpotitEarly hopes to improve early diagnosis, which is vital for successful treatment. The company is dedicated to making cancer detection easier and less invasive, meeting the needs of both patients and healthcare professionals. Through its distinct approach, SpotitEarly plays a key role in advancing health management and early intervention tactics.
How much funding has SpotitEarly raised?
SpotitEarly has raised $20.4M across 3 rounds on record. The most recent is an undisclosed round of $100k announced in Dec 2025.
When did SpotitEarly last raise funding?
SpotitEarly's most recent funding round on record is an undisclosed round of $100k, announced in Dec 2025.
Who founded SpotitEarly?
FundedIQ lists Ariel Ben Dayan (Founder), Ohad Sharon (Founder), Udi Bobrovsky (Founder) at SpotitEarly.
Where is SpotitEarly headquartered?
SpotitEarly is based in Englewood, New Jersey, United States.
How many employees does SpotitEarly have?
SpotitEarly is in the 11-50 employee band.
How does SpotitEarly's funding compare to other Biotechnology startups?
SpotitEarly's latest round of $100k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's SpotitEarly Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SpotitEarly is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.